FHS|^~\&||^2.16.840.1.114222.4.1.150^ISO| ^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511232332100
BHS|^~\&||^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|2005112323321101
MSH|^~\&|OE|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912102||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P281112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||196712|M||2076-6^NativeHawaiian or Other Pacific Islander^2.16.840.1.113883.6.238^H^^L|^^^OR^97005^USA^^^OR067|WASHINGTON ||||||V281112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2186-5^Not Hispanic or Latino^2.16.840.1.113883.6.238^N^^L|
ORC|RE|
OBR|1||EM-811|6412-1^GIARDIA LAMBLIA AG^2.16.840.1.113883.6.1^182204^GIARDIA LAMBLIA, DIRECT, EIA^L|||200511220300|||||||200511221131||||||||||F|
OBX|1|CE|6412-1^GIARDIA LAMBLIA AG^2.16.840.1.113883.6.1^182204^GIARDIA LAMBLIA, DIRECT, EIA^L||l-50701^Giardia, NOS^SNM^GAP^POSITIVE^L|||A|||F|||200511221354|^LABCORP BURLINGTON^CLIA||
NTE|1|L|POSITIVE
NTE|2|L|Giardia antigen detected.
MSH|^~\&|OE|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912132||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P291112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||198402|F||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|^^^OR^97005^USA^^^OR067|WASHINGTON ||||||V291112205^^^&2.16.840.1.114222.4.3.3.1&ISO
OBR|1||EM-8.1.2|^^^717009^BRUCELLA TEST^L|||200511220600|||||||200511221357|BLDV&BLOOD VENOUS||||||||||F
OBX|1|SN|5066-6^BRUCELLA ABORTUS AB^2.16.840.1.113883.6.1||^100^:^150|mcg/dL||H|||F|||20051122135813|||
NTE|1|L|                               (Children under 16 years)
NTE|2|L|                              Detection Limit = 1 mcg/dL
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P301112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||199912|F||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|^^^OR^97005^USA^^^OR067|WASHINGTON ||||||V301112205^^^&2.16.840.1.114222.4.3.3.1&ISO
OBR|1||EM-83|^^^160218^Rubeola Antibodies, IgM^L|||200511220100|||||||200511220755|||||||||||F
OBX|1|SN|7963-2^RUBEOLA VIRUS AB.IGM^2.16.840.1.113883.6.1^160219^Rubeola Antibodies, IgM^L||^5.60|AU|0.00-0.89|H|||F|||20051121100258|^LABCORP BURLINGTON^CLIA||
NTE|1|L|Note: The presence of           Negative           <0.90
NTE|2|L|IgM specific antibody           Borderline     0.90-1.10
NTE|3|L|should be interpreted in        Positive           >1.10
NTE|4|L|conjuction with the patient's
NTE|5|L|clinical history and exposure
NTE|6|L|risk when an acute infection
NTE|7|L|is suspected.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P311112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||198402|F||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|^^^OR^97005^USA^^^OR067|WASHINGTON ||||||V311112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-84|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511221655|||||||200511221719|||||||||||F|||||||||||
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||L-2A901^Chlamydia trachomatis^SNM^MCTP^POSITIVE:^L|||A|||F|||200511221256|26D0444173^LABCORP KANSAS CITY^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Chlamydia trachomatis by DNA probe.
NTE|3|L|**Verified by repeat analysis**
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P321112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||200512|F||2054-5^Black or African American^2.16.840.1.113883.6.238^AA^African American^L|^^^OR^97005^USA^^^OR067|WASHINGTON ||||||V321112205^^^&2.16.840.1.114222.4.3.3.1&ISO
OBR|1||EM-851|^^^164020^HSV I/II, IGG/RFX TYPE II IGG^L|||200511221110|||||||200511221057|||||||||||F|
OBX|1|SN|5209-2^HERPES SIMPLEX VIRUS 2 AB.IGG^2.16.840.1.113883.6.1^163151^HSV II IgG,Type Spec^L||^1.5|Index|0.0-0.8|H|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||EIA
NTE|1|L|Note: Negative indicates no antibodies  Negative     <0.9
NTE|2|L|detected to HSV-2. Equivocal may        Equivocal 0.9-1.0
NTE|3|L|suggest early infection. If clinically  Positive  >or=1.1
NTE|4|L|appropriate, retest at later date.
NTE|5|L|Positive indicates antibodies detected to
NTE|6|L|HSV-2; coinfection with HSV 1 cannot be
NTE|7|L|excluded.
OBX|2|NM|21612-7^REPORTED PATIENT AGE^2.16.840.1.113883.6.1||20|d^Days^2.16.840.1.113883.6.8|||||F<CR> 
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P331112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||199805|F||2054-5^Black or African American^2.16.840.1.113883.6.238^AA^African American^L|^^^OR^97005^USA^^^OR067|SUMTER||||||V331112205^^^&2.16.840.1.114222.4.3.3.1&ISO
OBR|1||EM-8.9|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1|||200511220940|||||||200511222323|||||||||||F|
OBX|1|CE|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1^006726^Hep A Ab, Total^L||^^^P^POSITIVE^L|||A|||F|||20051122|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P341112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||199805|F||2054-5^Black or African American^2.16.840.1.113883.6.238^AA^African American^L|^^^OR^97005^USA^^^OR067|WASHINGTON ||||||V341112205^^^&2.16.840.1.114222.4.3.3.1&ISO
OBR|1||EM-8.10|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1|||200511220940|||||||200511222327|||||||||||F|
OBX|1|CE|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1^006726^Hep A Ab, Total^L||^^^P^POSITIVE^L|||A|||F|||20051122|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P341112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||199805|U||1002.5^Native American^2.16.840.1.113883.6.238^AL^Native Alaskan^L|| ||||||V341112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-8.11|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1|||200511220940|||||||200511222323|||||||||||F
OBX|1|CE|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1^006726^Hep A Ab, Total^L||^^^P^POSITIVE^L|||A|||F|||20051122|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P351112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||198710|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V351112205^^^&2.16.840.1.114222.4.3.3.1&ISO
OBR|1||EM-8.12|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511230200|||||||200511230901||G82291^SMITH|^^^^917^3457574||||||||F|||||||2323PRI^LABORATORIAN^PRINCIPAL||||
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||L-2A901^Chlamydia trachomatis^SNM^MCTP^POSITIVE:^L|||A|||F|||20051124081341|^LABCORP BURLINGTON^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Chlamydia trachomatis by DNA probe.
NTE|3|L|
OBX|2|CE|23908-7^NEISSERIA GONORRHOEAE DNA^2.16.840.1.113883.6.1^098004^N gonorrhoeae by DNA Probe^L||L-22201^Neisseria gonorrhoeae^SNM^MGCP^POSITIVE:^L|||A|||F|||20051124081341|^LABCORP BURLINGTON^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Neisseria gonorrhoeae by DNA probe.
NTE|3|L|Note: Test valid for male urethral and female
NTE|4|L|      endocervical specimens only.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P361112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V361112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2135-2^Hispanic or Latino
ORC|RE|
OBR|1||EM-8.14|5292-8^REAGIN AB^2.16.840.1.113883.6.1^006072^RPR^L|||200511230100|||||||200511230929|||||||||||F|
OBX|1|CE|5292-8^REAGIN AB^2.16.840.1.113883.6.1^006072^RPR^L||^^^REA^Reactive^L||Non-Reactive|A|||F|||20051123092959|34D0655059^LABCORP BURLINGTON^CLIA||FLOC
NTE|1|L|Reactive
OBX|2|SN|11084-1^REAGIN AB^2.16.840.1.113883.6.1^006464^RPR, Quant.^L|1|^1^:^80||=<1:1|H|||F|||20051123093013|34D0655059^LABCORP BURLINGTON^CLIA||
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P371112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V371112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2135-2^Hispanic or Latino^2.16.840.1.113883.6.238^H^^L
OBR|1||EM-9.1|^^^550285^QUANT, RNA PCR, NON-GRAPH^L|||200511230100|||||||200511230938|||||||||||F
OBX|1|SN|20447-9^HIV 1 RNA^2.16.840.1.113883.6.1^162548^HIV-1 RNA BY PCR, Qn^L||^30076|COPIES/mL||A|||F|||20051123094004|34D0655059^LABCORP BURLINGTON^CLIA||PROBE.AMP.TAR
NTE|1|L|The result given above is the number of copies of HIV-1 RNA
NTE|2|L|per 1 mL of plasma (Viral Load). Changes of five-fold or
NTE|3|L|more in viral load are significant with regard to predicting
NTE|4|L|disease progression and monitoring efficacy of antiviral
NTE|5|L|therapy.
OBX|2|CE|20447-9^HIV 1 RNA^2.16.840.1.113883.6.1^162549^HIV-1 RNA BY PCR, Qn^L||^^^N^Negative^L|COPIES/mL||A|||F|||20051123094004|34D0655059^LABCORP BURLINGTON^CLIA||PROBE.AMP.TAR
NTE|1|L|Negative
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P381112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V381112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2135-2^Hispanic or Latino^2.16.840.1.113883.6.238^H^^L
ORC|RE|
OBR|1||EM-9.2|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511222014|||||||200511220133|||||||||||F|
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||^^^N^NEGATIVE:^L|||N|||C|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||PROBE
NTE|1|L|NEGATIVE UPON RETEST:
NTE|2|L|for Chlamydia trachomatis by DNA probe.
NTE|3|L|THIS IS A CORRECTED RESULT.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P391112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|F||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V391112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2135-2^Hispanic or Latino^2.16.840.1.113883.6.238^H^^L
ORC|RE|
OBR|1||EM-9.3|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511222014|||||||200511220133||G87591^WHARTON^EDITH|^^^^^402^5553164||||||||F
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||^^^N^NEGATIVE:^L|||N|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||PROBE
NTE|1|L|NEGATIVE UPON RETEST:
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P401112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V401112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-9.9|6412-1^GIARDIA LAMBLIA AG^2.16.840.1.113883.6.1^182204^GIARDIA LAMBLIA, DIRECT, EIA^L|||200511220300|||||||200511201133||^WHARTON^EDITH|^^^^^265^6955515||||||||F||||||||1110-BC^INTERPRETER^SECONDARY|||
OBX|1|CE|6412-1^GIARDIA LAMBLIA AG^2.16.840.1.113883.6.1^182204^GIARDIA LAMBLIA, DIRECT, EIA^L||l-50701^Giardia, NOS^SNM^GAP^POSITIVE^L|||A|||F|||20051120113549|34D0655059^LABCORP BURLINGTON^CLIA||
NTE|1|L|POSITIVE
NTE|2|L|Giardia antigen detected.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P411112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V411112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-9.11|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511230200|||||||200511230901||^RONSON^|^^^^917^3457574||||||||F|
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||L-2A901^Chlamydia trachomatis^SNM^MCTP^POSITIVE:^L|||A|||F|||20051124081341|34D0655059^LABCORP BURLINGTON^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Chlamydia trachomatis by DNA probe.
NTE|3|L|
OBX|2|CE|23908-7^NEISSERIA GONORRHOEAE DNA^2.16.840.1.113883.6.1^098004^N gonorrhoeae by DNA Probe^L||L-22201^Neisseria gonorrhoeae^SNM^MGCP^POSITIVE:^L|||A|||F|||20051124081341|34D0655059^LABCORP BURLINGTON^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Neisseria gonorrhoeae by DNA probe.
NTE|3|L|          Note: Test valid for male urethral and female
NTE|4|L|                endocervical specimens only.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P421112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V421112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-9.12|^^^303744^HEPATITIS PANEL (5)^L|||200511230100|||||||200511230906|||||||||||F|
OBX|1|CE|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1^006726^Hep A Ab, Total^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
OBX|2|CE|5196-1^HEPATITIS B VIRUS SURFACE AG^2.16.840.1.113883.6.1^006510^Hep B Surface Ag^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
OBX|3|CE|13952-7^HEPATITIS B VIRUS CORE AB^2.16.840.1.113883.6.1^006718^Hep B Core Ab, Tot^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
OBX|4|CE|13955-0^HEPATITIS C VIRUS AB^2.16.840.1.113883.6.1^140608^Hep C Virus Ab^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P431112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V431112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-9.14|^^^550285^QUANT, RNA PCR, NON-GRAPH^L|||200511230100|||||||200511230938||^MANSOUR|^^^^744^9135098||||||||F||||||||1010-BC^interpreter^ASSISTANT|TECH102^TECHNOLOGIST^MEDICAL||
OBX|1|SN|20447-9^HIV 1 RNA^2.16.840.1.113883.6.1^162548^HIV-1 RNA BY PCR, Qn^L||^30076|COPIES/mL||A|||F|||20051123094004|34D0655059^LABCORP BURLINGTON^CLIA||PROBE.AMP.TAR
NTE|1|L|The result given above is the number of copies of HIV-1 RNA
NTE|2|L|per 1 mL of plasma (Viral Load). Changes of five-fold or
NTE|3|L|more in viral load are significant with regard to predicting
NTE|4|L|disease progression and monitoring efficacy of antiviral
NTE|5|L|therapy.
OBX|2|CE|20447-9^HIV 1 RNA^2.16.840.1.113883.6.1^162549^HIV-1 RNA BY PCR, Qn^L||^^^N^Negative^L|COPIES/mL||A|||F|||20051123094028|34D0655059^LABCORP BURLINGTON^CLIA||PROBE.AMP.TAR
NTE|1|L|Negative
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P441112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V441112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-10.2|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511222014|||||||200511220133||7330^ASHBY^CHARLES^E^^^MD|^^^^^402^5553164||||||||F|||||||||TECH102^TECHNOLOGIST^MEDICAL||
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||^^^N^NEGATIVE:^L|||N|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||PROBE
NTE|1|L|NEGATIVE UPON RETEST:
NTE|2|L|for Chlamydia trachomatis by DNA probe.
NTE|3|L|THIS IS A CORRECTED RESULT.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P451112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V451112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-10.3|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511222013|||||||200511220133||7330^ASHBY^CHARLES^E^^^MD|^^^^^402^5553164||||||||F|||||||||1107-1^TECHNOLOGIST^MEDICAL||
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||^^^N^NEGATIVE:^L|||N|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||PROBE
NTE|1|L|NEGATIVE UPON RETEST:
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P461112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V461112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-10.4|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511222014|||||||200511220133||7330^ASHBY^CHARLES^E^^^MD|^^^^^402^5553164||||||||F|
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||^^^N^NEGATIVE:^L|||N|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||PROBE
NTE|1|L|NEGATIVE UPON RETEST:
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P471112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V471112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-10.5|6412-1^GIARDIA LAMBLIA AG^2.16.840.1.113883.6.1^182204^GIARDIA LAMBLIA, DIRECT, EIA^L|||200511220300|||||||200511201135||G87591^WHARTON^EDITH^M^^^MD|||||||||F|182204||||||||tech102^TECHNOLOGIST^MEDICAL||
OBX|1|CE|6412-1^GIARDIA LAMBLIA AG^2.16.840.1.113883.6.1^080381^RSLT#1^L|1|l-50701^Giardia, NOS^SNM^GAP^POSITIVE^L|||A|||F|||20051120113625|34D0655059^LABCORP BURLINGTON^CLIA||
NTE|1|L|POSITIVE
NTE|2|L|Giardia antigen detected.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P481112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V481112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-10.11|^^^096479^CHLAMYDIA/GONOCOCCUS DNA PROBE^L|||200511230200|||||||200511230901||^RONSON^|^^^^917^3457574||||||||F|
OBX|1|CE|20993-2^CHLAMYDIA TRACHOMATIS DNA^2.16.840.1.113883.6.1^098012^Chlamydia, DNA Probe^L||L-2A901^Chlamydia trachomatis^SNM^MCTP^POSITIVE:^L|||A|||F|||20051124081341|34D0655059^LABCORP BURLINGTON^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Chlamydia trachomatis by DNA probe.
NTE|3|L|
OBX|2|CE|23908-7^NEISSERIA GONORRHOEAE DNA^2.16.840.1.113883.6.1^098004^N gonorrhoeae by DNA Probe^L||L-22201^Neisseria gonorrhoeae^SNM^MGCP^POSITIVE:^L|||A|||F|||20051124081341|34D0655059^LABCORP BURLINGTON^CLIA||PROBE
NTE|1|L|POSITIVE:
NTE|2|L|for Neisseria gonorrhoeae by DNA probe.
NTE|3|L|          Note: Test valid for male urethral and female
NTE|4|L|                endocervical specimens only.
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P491112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V491112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||EM-10.12|^^^303744^HEPATITIS PANEL (5)^L|||200511230100|||||||200511230906||^MORSE^|^^^^^^||||||||F||||||||1010-BC^LABLADY^ASSISTANT|1107-1^LABTECH^MEDICAL||
OBX|1|CE|13951-9^HEPATITIS A VIRUS AB^2.16.840.1.113883.6.1^006726^Hep A Ab, Total^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
OBX|2|CE|5196-1^HEPATITIS B VIRUS SURFACE AG^2.16.840.1.113883.6.1^006510^Hep B Surface Ag^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
OBX|3|CE|13952-7^HEPATITIS B VIRUS CORE AB^2.16.840.1.113883.6.1^006718^Hep B Core Ab, Tot^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
OBX|4|CE|13955-0^HEPATITIS C VIRUS AB^2.16.840.1.113883.6.1^140608^Hep C Virus Ab^L||^^^P^POSITIVE^L|||A|||F|||20051123092448|34D0655059^LABCORP BURLINGTON^CLIA||EIA
NTE|1|L|POSITIVE
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P501112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V501112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2186-5^Not Hispanic or Latino^2.16.840.1.113883.6.238^N^Not hispanic^L
ORC|RE|
OBR|1||EM-10.14|^^^550285^QUANT, RNA PCR, NON-GRAPH^L|||200511230100|||||||200511230938|||||||||||F|
OBX|1|SN|20447-9^HIV 1 RNA^2.16.840.1.113883.6.1^162548^HIV-1 RNA BY PCR, Qn^L||^30076|COPIES/mL||A|||F|||20051123094004|34D0655059^LABCORP BURLINGTON^CLIA||PROBE.AMP.TAR
NTE|1|L|The result given above is the number of copies of HIV-1 RNA
NTE|2|L|per 1 mL of plasma (Viral Load). Changes of five-fold or
NTE|3|L|more in viral load are significant with regard to predicting
NTE|4|L|disease progression and monitoring efficacy of antiviral
NTE|5|L|therapy.
OBX|2|CE|20447-9^HIV 1 RNA^2.16.840.1.113883.6.1^162549^HIV-1 RNA BY PCR, Qn^L||^^^N^Negative^L|COPIES/mL||A|||F|||20051123094028|34D0655059^LABCORP BURLINGTON^CLIA||PROBE.AMP.TAR
NTE|1|L|Negative
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P511112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V511112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2186-5^Not Hispanic or Latino^2.16.840.1.113883.6.238^N^Not hispanic^L
ORC|RE|
OBR|1||36484902650|600-7^MICROORGANISM IDENTIFIED^2.16.840.1.113883.6.1^008300^BLOOD CULTURE, ROUTINE^L|||200112280940|||||||200112300436||^HENDRICKSON|^^^^^701^2803246||||||||F|||||||||||
OBX|1|CE|600-7^MICROORGANISM IDENTIFIED^2.16.840.1.113883.6.1^997181^RESULT 1^L|1|L-26201^Vibrio Cholerae^SNM^M520^VIBRIO CHOLERAE^L|||A|||F|||20051122|LABCORP KANSAS CITY^26D0444173^CLIA||
NTE|1|L|VIBRIO CHOLERAE
OBX|2|CE|600-7^MICROORGANISM IDENTIFIED^2.16.840.1.113883.6.1^997182^RESULT 2^L|1|L-20901^Listeria monocytogenes^SNM^M315^LISTERIA MONOCYTOGENES^L|||A|||F|||20051122|LABCORP KANSAS CITY^26D0444173^CLIA||
NTE|1|L|LISTERIA MONOCYTOGENES
OBX|3|CE|600-7^MICROORGANISM IDENTIFIED^2.16.840.1.113883.6.1^997183^RESULT 3^L|1|L-22202^Neisseria monocytogenes^SNM^M469^NEISSERIA MENINGITIDIS^L|||A|||F|||20051122|LABCORP KANSAS CITY^26D0444173^CLIA||
NTE|1|L|NEISSERIA MENINGITIDIS
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P521112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|F||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V521112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||MS-1|^^^163030^B PERTUSSIS IGG/IGM AB, QUANT^L|||200511221145|||||||200511222050|||||||||||F||||||786.2^Cough^IC9|||||
OBX|1|SN|24127-3^BORDETELLA PERTUSSIS.TOXIN AB.IGG^2.16.840.1.113883.6.1^161749^B pertussis IgG Ab, Quant^L||^13|PanBio Units|0-8|H|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||EIA
NTE|1|L|                                           Negative           <9
NTE|2|L|                                           Equivocal        9-11
NTE|3|L|                                           Positive          >11
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P531112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||197608|M||2054-5^Black or African American^2.16.840.1.113883.6.238^AA^African American^L|| ||||||V531112205^^^&2.16.840.1.114222.4.3.3.1&ISO
ORC|RE|
OBR|1||MS-2|^^^008144^STOOL CULTURE^L|||200511221200|||||||200511220800|||||||||||F|||||||||||
OBX|1|CE|^^^080173^RSLT#1^L|1|^^^CJ^CAMPYLOBACTER JEJUNI^L|||A|||F|||20051122|26D0444173^LABCORP KANSAS CITY^CLIA||
NTE|1|L|CAMPYLOBACTER JEJUNI
NTE|2|L|     Moderate growth
NTE|3|L|    .
MSH|^~\&|LIS|^2.16.840.1.114222.4.1.150^ISO|^2.16.840.1.114222.4.3.2.3^ISO|^2.16.840.1.114222^ISO|200511221912133||ORU^R01^ORM_R01|POR012005112218321330035|D|2.5|||||||||BioSense-V1.04^PHIN^2.16.840.1.114222.4.1^ISO
PID|1||P541112205^^^&2.16.840.1.114222.4.3.3.1&ISO||””||200003|F||2106-3^White^2.16.840.1.113883.6.238^C^Caucasian^L|| ||||||V541112205^^^&2.16.840.1.114222.4.3.3.1&ISO||||2186-5^Not Hispanic or Latino^2.16.840.1.113883.6.238^N^Not hispanic^L
ORC|RE|
OBR|1||PA-3|5196-1^HEPATITIS B VIRUS SURFACE AG^2.16.840.1.113883.6.1^006510^Hep B Surface Ag^L|||200511220935|||||||200511222310||^LEMON|^^^^^402^4796333||||||||C|||||||||||
OBX|1|SN|^^^717009^Lead, Blood (Pediatric)^L||^2.0|mcg/dL|0-9|A|||F|||200511220304|26D0444173^LABCORP KANSAS CITY^CLIA||
NTE|1|L|                               (Children under 16 years)
NTE|2|L|                              Detection Limit = 1 mcg/dL
BTS|28
FTS|1